Atom Investors LP - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 62 filers reported holding CARDIFF ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 19.84 and the average weighting 0.0%.

Quarter-by-quarter ownership
Atom Investors LP ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q3 2023$25,434
-5.4%
18,2980.0%0.01%
-40.0%
Q2 2023$26,898
-10.9%
18,2980.0%0.01%
-37.5%
Q1 2023$30,192
+17.9%
18,2980.0%0.02%
+23.1%
Q4 2022$25,617
-8.5%
18,2980.0%0.01%
+30.0%
Q3 2022$28,000
-62.2%
18,298
-45.9%
0.01%
-68.8%
Q2 2022$74,000
-11.9%
33,7980.0%0.03%
-17.9%
Q1 2022$84,00033,7980.04%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
CAXTON CORP 2,522,083$16,797,00013.61%
Octagon Capital Advisors LP 982,753$6,545,0001.61%
Altium Capital Management LP 348,888$2,324,0000.61%
ACT CAPITAL MANAGEMENT, LLC 102,500$683,0000.35%
Eventide Asset Management 1,670,399$11,125,0000.15%
Artal Group S.A. 750,000$4,995,0000.11%
Virtus ETF Advisers LLC 25,770$172,0000.08%
HighVista Strategies LLC 15,501$103,0000.07%
ELKHORN PARTNERS LIMITED PARTNERSHIP 13,500$90,0000.05%
SCHOLTZ & COMPANY, LLC 16,625$111,0000.04%
View complete list of CARDIFF ONCOLOGY INC shareholders